Drugmakers Pfizer Inc. and Allergan Plc are scrambling to determine whether to proceed with their plan to merge and move Pfizer's address — but not its operations or headquarters — to lower-tax ...

That’s the question a group of attorneys representing multinational corporations recently raised at a Treasury Department hearing on the proposed changes to U.S. tax law. Now, corporations are ...

The U.S. Treasury Department announced its final anti-inversion rules this week, emerging from a firestorm of corporate lobbying with the core tenets of the rules still very much in place. The ...

The White House said Wednesday that the Treasury Department’s new rules aimed at curbing corporate inversions were not specifically targeted at the prospective Pfizer and Allergen merger that the ...

Reporting from Washington — The $150-billion proposed merger of Pfizer Inc. and Ireland-based Allergan has been scrapped, becoming the first casualty of an Obama administration crackdown on companies ...

U.S. companies will find it much harder to reduce their taxes by merging with foreign firms under new rules introduced by the Obama administration, and that's already throwing the fate of one big deal ...

A regulatory effort by the Obama administration to crack down on tax deals is facing backlash from business groups and lawmakers on both sides of the aisle. While the Internal Revenue Service (IRS) ...

The IRS issued a package of proposed and temporary regulations on Monday designed to reduce the tax benefits and incentives for corporate inversions. These new rules aim to curtail an inverted company ...

The going has been tough for the healthcare space has this year following the slide in biotechnology stocks. The pain seems to have aggravated since the U.S. Treasury Department and Internal Revenue ...

Less than 24 hours after the Obama administration escalated its battle against corporate tax inversions, the outcome of at least one major pending U.S. merger seemed clouded by doubt Tuesday. The ...

Drugmakers Pfizer Inc. (PFE) and Allergan Plc (AGN) are scrambling to determine whether to proceed with their plan to merge and move Pfizer's address - but not its operations or headquarters - to ...